Cargando…

Therapeutic Drug Monitoring and Nephrotoxicity of Teicoplanin Therapy in Chinese Children: A Retrospective Study

PURPOSE: This study aims to 1) describe the distribution characteristics of teicoplanin trough concentration (C(min)) and explore the related influencing factors and 2) evaluate the nephrotoxicity of teicoplanin in children. PATIENTS AND METHODS: A cohort of children who were treated with teicoplani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Dan, Zhang, Tao, Mi, Jie, Dong, Yuzhu, Liu, Yang, Zhang, Ying, Zhang, Di, Wang, Taotao, Cheng, Hua, Dong, Yalin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669515/ https://www.ncbi.nlm.nih.gov/pubmed/33209040 http://dx.doi.org/10.2147/IDR.S272982

Ejemplares similares

Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients
por: Zhang, Tao, et al.
Publicado: (2020)

Is Therapeutic Drug Monitoring of Teicoplanin Useful?
por: Kim, Shin-Woo
Publicado: (2014)

Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy
por: Workum, J D, et al.
Publicado: (2020)

Accuracy of Therapeutic Drug Monitoring of Teicoplanin at the Onset of Febrile Neutropenia
por: Takigawa, Masaki, et al.
Publicado: (2023)

Therapeutic Drug Concentrations of Teicoplanin in Clinical Settings
por: Nah, So-Yun, et al.
Publicado: (2014)

Optimal Use and Need for Therapeutic Drug Monitoring of Teicoplanin in Children: A Systematic Review
por: Choi, Joon-sik, et al.
Publicado: (2023)

Population pharmacokinetics and dosing optimization of unbound teicoplanin in Chinese adult patients
por: Fu, Wen-Qian, et al.
Publicado: (2022)

Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring
por: Hanai, Yuki, et al.
Publicado: (2022)

Therapeutic Drug Level Monitoring of Teicoplanin in Korean Pediatric Patients with Normal versus Impaired Renal Function
por: Choi, Joon-sik, et al.
Publicado: (2020)

Teicoplanin: an alternative drug for the treatment of COVID-19?
por: Baron, Sophie Alexandra, et al.
Publicado: (2020)

Increased incidence of teicoplanin-non-susceptible Staphylococcus epidermidis strains: a 6-year retrospective study
por: Kim, Subin, et al.
Publicado: (2023)

Arbekacin as an Alternative Drug to Teicoplanin for the Treatment of MRSA Infection
por: Hwang, Ji-Hee, et al.
Publicado: (2016)

Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate–severe Gram-positive infections
por: Zhou, Lijuan, et al.
Publicado: (2018)

Teicoplanin Dosing Strategy for Treatment of Staphylococcus aureus in Korean Patients with Neutropenic Fever
por: Ahn, Byung-Jin, et al.
Publicado: (2011)

Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19
por: Azam, Faizul
Publicado: (2021)

Teicoplanin—A New Use for an Old Drug in the COVID-19 Era?
por: Vimberg, Vladimir
Publicado: (2021)

Prognosis of patients with methicillin-resistant Staphylococcus aureus bloodstream infection treated with teicoplanin: a retrospective cohort study investigating effect of teicoplanin minimum inhibitory concentrations
por: Wang, Jann-Tay, et al.
Publicado: (2013)

Teicoplanin pharmacokinetics during albumin dialysis
por: Weiler, Stefan, et al.
Publicado: (2010)

Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents
por: Hong, Min Hee
Publicado: (2021)

Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
por: Dong, Yuzhu, et al.
Publicado: (2022)

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) with Teicoplanin: A Case Report
por: Ebrahimpour, Sholeh, et al.
Publicado: (2016)

Effectiveness, nephrotoxicity, and therapeutic drug monitoring of polymyxin B in nosocomial pneumonia among critically ill patients
por: Ye, Qinghua, et al.
Publicado: (2022)

Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database
por: Imai, Shungo, et al.
Publicado: (2020)

Tools for the Individualized Therapy of Teicoplanin for Neonates and Children
por: Ramos-Martín, V., et al.
Publicado: (2017)

Synthesis of Antiviral Perfluoroalkyl Derivatives of Teicoplanin and Vancomycin
por: Bereczki, Ilona, et al.
Publicado: (2020)

Clinical outcomes of teicoplanin use in the OPAT setting
por: Dabrowski, Hannah, et al.
Publicado: (2020)

The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin
por: Bereczki, Ilona, et al.
Publicado: (2022)

Therapeutic Effect of Teneligliptin in Drug-Induced Nephrotoxicity: An In-Vitro Study
por: Becerir, Tülay, et al.
Publicado: (2022)

Teicoplanin as an Effective Alternative to Vancomycin for Treatment of MRSA Infection in Chinese Population: A Meta-analysis of Randomized Controlled Trials
por: Peng, Yang, et al.
Publicado: (2013)

Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
por: Chen, Chao‐Yang, et al.
Publicado: (2023)

Clinical Efficacy and Cost-Effectiveness of β-Lactam/β-Lactamase Inhibitor Combinations and Carbapenems in Liver Cirrhosis Patients with Gram-Negative Bacteria Bloodstream Infection
por: Dong, Yuzhu, et al.
Publicado: (2020)

A Case of Hypersensitivity Syndrome to Both Vancomycin and Teicoplanin
por: Kwon, Hyouk-Soo, et al.
Publicado: (2006)

An Analogue of the Antibiotic Teicoplanin Prevents Flavivirus Entry In Vitro
por: De Burghgraeve, Tine, et al.
Publicado: (2012)

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
por: Matsumoto, Kazuaki, et al.
Publicado: (2016)

Effects of teicoplanin on cell number of cultured cell lines
por: Kashkolinejad-Koohi, Tahere, et al.
Publicado: (2015)

Teicoplanin inhibits Ebola pseudovirus infection in cell culture
por: Wang, Yizhuo, et al.
Publicado: (2016)

Teicoplanin Suppresses Vegetative Clostridioides difficile and Spore Outgrowth
por: Ojha, Suvash Chandra, et al.
Publicado: (2021)

In Silico Prediction and Insights Into the Structural Basis of Drug Induced Nephrotoxicity
por: Shi, Yinping, et al.
Publicado: (2022)

TIGAR Protects Cochlear Hair Cells against Teicoplanin-Induced Damage
por: Zhang, Qiongmin, et al.
Publicado: (2023)

Population Pharmacokinetics and Dosage Optimization of Teicoplanin in Children With Different Renal Functions
por: Gao, Liuliu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ptq0mjo9a6b0rqmonahvkuuepb